Inventor
SONG TAE K
US19 patents
⚠️ This page may combine multiple inventors who share the name “SONG TAE K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALLERGAN INC
12 patentsUS5723666AMar 3, 1998
Oxime substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
ALLERGAN INC71 citations96
US5648503AJul 15, 1997
Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
ALLERGAN INC78 citations96
US5605915AFeb 25, 1997
Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
ALLERGAN INC74 citations96
US5599967AFeb 4, 1997
Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl of heteroaryl group having retinoid-like biological activity
ALLERGAN INC65 citations96
US5534641AJul 9, 1996
Acetylenes disubstituted with 2-tetrahydropyranoxyaryl and aryl or heteroaryl groups having retinoid-like biological activity
ALLERGAN INC84 citations96
US5498795AMar 12, 1996
Acetylenes disubstituted with hydroxyaryl and aryl or heteroaryl groups having retinoid-like biological activity
ALLERGAN INC101 citations96
US5618943AApr 8, 1997
Acetylenes disubstituted with a 5 OXO substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
ALLERGAN INC66 citations95
US6660755B2Dec 9, 2003
Substituted diaryl or diheteroaryl methans, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
ALLERGAN INC16 citations92
US6455701B1Sep 24, 2002
Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
ALLERGAN INC27 citations92
US5698700ADec 16, 1997
Acetylenes disubstituted with 2-tetrahydropyranoxyaryl and aryl or heteroaryl groups having retinoid-like biological activity
ALLERGAN INC36 citations92
US5747542AMay 5, 1998
Oxo-substituted tetrahydronaphthalene derivatives having retinold and/or retinoid antagonist-like biological activity
ALLERGAN INC13 citations73
US5847160ADec 8, 1998
Acetylenes disubstituted with 2-tetrahydropyranoxy-aryl and aryl of heteroaryl groups having retinoid-like biological activity
ALLERGAN INC0 citations52
ALLERGAN SALES INC
6 patentsUS5919970AJul 6, 1999
Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
ALLERGAN SALES INC227 citations99
US6235923B1May 22, 2001
Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
ALLERGAN SALES INC42 citations96
US6225494B1May 1, 2001
Trisubstituted phenyl derivatives having retinoid agonist or inverse agonist type biological activity
ALLERGAN SALES INC62 citations96
US6037488AMar 14, 2000
Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
ALLERGAN SALES INC66 citations96
US6025388AFeb 15, 2000
Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids
ALLERGAN SALES INC18 citations91
US6369100B1Apr 9, 2002
Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids
ALLERGAN SALES INC1 citations50